Position in MRK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$504,105
+$47,846 QoQ
Shares Held
3,923
+3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,691
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MERIDIAN INVESTMENT COUNSEL INC. holds $23,634,584 across 8 Drug Manufacturers - General names. MRK ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
25,506 | $6,418,329 | |
| 2 | JNJ |
Johnson & Johnson
|
22,704 | $5,766,134 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
31,450 | $3,973,393 | |
| 4 | NVO |
Novo Nordisk A S
|
63,091 | $3,024,582 | |
| 5 | AMGN |
Amgen Inc
|
6,995 | $2,533,029 | |
| 6 | PFE |
Pfizer Inc
|
50,187 | $1,208,502 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
3,923 | $504,105 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,584 | $206,510 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $504,105 | 3,923 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $456,259 | 3,793 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $471,775 | 4,482 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $400,933 | 4,777 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $378,147 | 4,777 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $428,963 | 4,779 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $475,414 | 4,779 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $542,703 | 4,779 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $591,640 | 4,779 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $623,991 | 4,729 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $522,968 | 4,797 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $493,851 | 4,797 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $553,525 | 4,797 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $504,926 | 4,746 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $526,568 | 4,746 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $447,479 | 5,196 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $451,291 | 4,950 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $406,147 | 4,950 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $440,296 | 5,745 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $422,493 | 5,625 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $437,456 | 5,625 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $433,631 | 5,625 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $460,124 | 5,625 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $466,593 | 5,625 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $365,384 | 4,725 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $363,541 | 4,725 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||